galantamine and oxytocin

galantamine has been researched along with oxytocin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Adams, HA; Blanchard, JJ; Buchanan, RW; Carpenter, WT; Cohen, AS; Gold, J; Kelly, DL; McMahon, RP; Mitchell, KR; Strauss, GP1
Buchanan, RW; Carpenter, WT; Gold, JM; Kelly, DL; Koola, MM; McMahon, RP; Strauss, GP; Weiner, E1
Allam, M; El-Ganainy, SO; Elbahnasi, AI; Ghazy, AA; Gowayed, MA; Mansour, AM; Soliman, OA1

Reviews

1 review(s) available for galantamine and oxytocin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

2 trial(s) available for galantamine and oxytocin

ArticleYear
The effects of oxytocin and galantamine on objectively-defined vocal and facial expression: Data from the CIDAR study.
    Schizophrenia research, 2017, Volume: 188

    Topics: Adult; Antipsychotic Agents; Facial Expression; Galantamine; Humans; Interpersonal Relations; Interview, Psychological; Middle Aged; Neuropsychological Tests; Oxytocin; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Social Behavior; Speech Production Measurement; Treatment Outcome; Video Recording; Voice; Young Adult

2017
A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.
    Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:4

    Topics: Administration, Intranasal; Adult; Cognitive Dysfunction; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Nootropic Agents; Oxytocics; Oxytocin; Pessimism; Schizophrenia; Schizophrenic Psychology; Treatment Outcome

2017

Other Studies

1 other study(ies) available for galantamine and oxytocin

ArticleYear
Intranasal Oxytocin Attenuates Cognitive Impairment, β-Amyloid Burden and Tau Deposition in Female Rats with Alzheimer's Disease: Interplay of ERK1/2/GSK3β/Caspase-3.
    Neurochemical research, 2022, Volume: 47, Issue:8

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Caspase 3; Cognitive Dysfunction; Disease Models, Animal; Female; Galantamine; Glycogen Synthase Kinase 3 beta; MAP Kinase Signaling System; Oxytocin; Rats; tau Proteins

2022